Cell-Killing Protein Offers Hope for Defeating Cancer, Diabetes
By wchung | 07 Apr, 2026
A team of Australian scientists published their findings on the workings of a protein that kills cells in Monday’s issue of the journal Nature. Their work raises hope of developing drugs that can zero in on cells that cause cancer and other immune system disorders.
The protein perforin has been revealed to be the body’s defense against rogue cells that have become cancerous or hijacked by viruses by punching holes into the cells to allow toxic enzymes to invade and destroy them. This work is deemed a major advance in the field of immunology. By uncovering the precise mechanism of perforin, researchers will be able to focus their efforts on more effective and targeted ways to defeat diseases like cancer and malaria, and even disorders like diabetes.
The findings are the fruits of 10 years of collaboration between a team headed by Professor James Whisstock, an Australian Research Council Federation fellow at Monash University, a second Australian team at the Peter McCallum Cancer Institute in Melbourne, and scientists at Birkbeck College in London of Britain.
CANBERRA
Articles
- US Crude Premiums Hits Record Levels as Asia, Europe Compete for Supply
- China Targets Taiwan's Chip Prowess to Avoid 'Containment' Says Taipei
- Nvidia's Buy of Main Supercomputer Software Raises AI Chip Neutrality Concerns
- SpaceX Plans Early June Pre-IPO Roadshow
- OpenAI's Jason Kwon Asks State AGs to Probe Musk's 'Anti-Competitive Behavior’
- Broadcom Scores Long-Term Deal to Develop Custom AI Chips for Google
- Samsung Q1 Profits Surge 8-Fold on AI Demand
- Judge Tana Lin Dismisses Lead-Scare Class Action Against Stanley Tumblers
- Fed Governors See Urgent Inflation Warning Signs
- Trump Continues Uncontrolled Trash Talking
